Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. MRI-based radiomics feature combined with tumor markers to predict TN staging of rectal cancer.Journal of robotic surgery · 2024
   Article
2. Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways.Cells · 2022
   Review
3. Emerging Role of LncRNAs in Autoimmune Lupus.Inflammation · 2022
   Review
4. The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells.Cancers · 2021
   Review
5. The function of lncRNAs in the pathogenesis of osteoarthritis.Bone & joint research · 2021
   Article
6. lncRNAs: function and mechanism in cartilage development, degeneration, and regeneration.Stem cell research & therapy · 2019
   Review
7. TCF-4 Regulated lncRNA-XIST Promotes M2 Polarization Of Macrophages And Is Associated With Lung Cancer.OncoTargets and therapy · 2019
   Article
8. Tissue Expression Difference between mRNAs and lncRNAs.International journal of molecular sciences · 2018
   Article
9. Metabolic characterization and pathway analysis of berberine protects against prostate cancer.Oncotarget · 2017
   Article

Corrections and comments

• Erratum for
  Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.2015

Authors and funding

9 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.